Compounded NAD+ at a glance

Compounded NAD+ through Cora Health is a coenzyme, prepared as a compounded injectable solution if a licensed provider prescribes it. VialsRx, a US-licensed 503A compounding pharmacy, prepares it, and compounded NAD+ is not FDA-approved. The compounded NAD+ membership through Cora Health is $159 billed monthly, $417 every 3 months, $768 every 6 months, or $1,428 every 12 months. Each price covers your provider visit and check-ins, the medication if it is prescribed, and shipping, with no other fees. Cora Health connects patients with licensed providers, who decide whether to prescribe; Cora Health does not prescribe, compound or dispense medication.

Is compounded NAD+ FDA-approved?

FDA's Pharmacy Compounding Advisory Committee voted in May 2017 not to add NAD (nicotinamide adenine dinucleotide, the ingredient in compounded NAD+) to FDA's list of bulk ingredients pharmacies can use in 503A compounding, and in a 2019 proposed rule FDA proposed not to add it. The committee's votes are advisory, and the rule has not been finalized. Compounded NAD+ is not FDA-approved.

FDA does not review compounded drugs for safety, effectiveness or quality before they reach patients.

Sources

• FDA, 503A bulk drug substances categories, updated May 14, 2026
• Federal Register, proposed rule on the 503A bulks list (84 FR 46688), September 5, 2019
• FDA, Compounding and the FDA: Questions and Answers

Prices and FDA status in detail

• Compounded NAD+ cost across providers
• FDA status of all four medications
• NAD+ injection vs IV, nasal spray and pills
• Compounded Injection Price Index

Other compounded medications through Cora Health

• Compounded Sermorelin
• Compounded Glutathione
• Compounded MIC + B12
• All four on one page